Free Trial
LON:BVX

BiVictriX Therapeutics (BVX) Share Price, News & Analysis

BiVictriX Therapeutics logo

About BiVictriX Therapeutics Stock (LON:BVX)

Advanced Chart
Remove Ads

Key Stats

Today's Range
N/A
50-Day Range
10
10
52-Week Range
N/A
Volume
1.54 million shs
Average Volume
108,326 shs
Market Capitalization
£8.25 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

BiVictriX Therapeutics Plc, a biotechnology company, engages in the development of cancer therapies in the United Kingdom. The company develops Bi-Cygni therapeutics, which are selective for cancer types. Its lead program is BVX001, focuses on acute myeloid leukaemia, as well as develops BVX002 and BVX003 for various blood cancers and solid tumours. BiVictriX Therapeutics Plc was founded in 2016 and is headquartered in Macclesfield, the United Kingdom.

Remove Ads
Receive BVX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BiVictriX Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

BVX Stock News Headlines

$2 Trillion Disappears Because of Fed's Secretive New Move
$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being carried out by the Fed that has nothing to do with lowering or raising interest rates... but could soon have an enormous impact on your wealth.
BiVictriX Therapeutics PLC (BVX)
BiVictriX Therapeutics' former chair moves on
See More Headlines

BVX Stock Analysis - Frequently Asked Questions

Shares of BVX stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that BiVictriX Therapeutics investors own include AutoZone (AZO), Intel (INTC), Premier African Minerals (PREM), Rolls-Royce Holdings plc (RR), TJX Companies (TJX), Abacus Health Products (ABAHF) and Aurora Cannabis (ACB).

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
LON:BVX
CIK
N/A
Phone
N/A
Fax
N/A
Employees
17
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
£-2,670,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
2.20
Book Value
GBX 3 per share
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
£8.25 million
Optionable
Not Optionable
Beta
-0.73
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (LON:BVX) was last updated on 4/4/2025 by MarketBeat.com Staff
From Our Partners